BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo.
about
P90 RSK arranges Chk1 in the nucleus for monitoring of genomic integrity during cell proliferationFGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesisActivation and function of the MAPKs and their substrates, the MAPK-activated protein kinasesThe selectivity of protein kinase inhibitors: a further updateAKT/PKB signaling: navigating downstreamMolecular Targeting of ERKs/RSK2 Signaling Axis in Cancer PreventionRSK isoforms in cancer cell invasion and metastasisCrystal structures of the N-terminal kinase domain of human RSK1 bound to three different ligands: Implications for the design of RSK1 specific inhibitorsInsights into the inhibition of the p90 ribosomal S6 kinase (RSK) by the flavonol glycoside SL0101 from the 1.5 Å crystal structure of the N-terminal domain of RSK2 with bound inhibitor.Dual kinase-bromodomain inhibitors for rationally designed polypharmacologyp90 ribosomal S6 kinase: a potential therapeutic target in lung cancerRSK3: A regulator of pathological cardiac remodelingCrucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(βTrCP) E3 ubiquitin ligase and regulates survival and autophagyProgestins activate 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) in breast cancer cellsRSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively regulating MAPK activationNovel role for p90 ribosomal S6 kinase in the regulation of cardiac myofilament phosphorylationbetaTrCP- and Rsk1/2-mediated degradation of BimEL inhibits apoptosisUncoupling of the LKB1-AMPKalpha energy sensor pathway by growth factors and oncogenic BRAFThe p90 ribosomal S6 kinase (RSK) is a mediator of smooth muscle contractilityInvestigation of LKB1 Ser431 phosphorylation and Cys433 farnesylation using mouse knockin analysis reveals an unexpected role of prenylation in regulating AMPK activityStructural insights into the polypharmacological activity of quercetin on serine/threonine kinasesSH3P2 is a negative regulator of cell motility whose function is inhibited by ribosomal S6 kinase-mediated phosphorylation.Bacterial Expression, Purification and In Vitro Phosphorylation of Full-Length Ribosomal S6 Kinase 2 (RSK2)Extracellular Signal-regulated Kinase (ERK)-dependent Phosphorylation of Y-Box-binding Protein 1 (YB-1) Enhances Gene Expression in Granulosa Cells in Response to Follicle-stimulating Hormone (FSH)The unusual mechanism of inhibition of the p90 ribosomal S6 kinase (RSK) by flavonol rhamnosides.Phosphorylation of eukaryotic translation initiation factor 4B (EIF4B) by open reading frame 45/p90 ribosomal S6 kinase (ORF45/RSK) signaling axis facilitates protein translation during Kaposi sarcoma-associated herpesvirus (KSHV) lytic replicationRSK2 Binding Models Delineate Key Features for ActivityCodependent functions of RSK2 and the apoptosis-promoting factor TIA-1 in stress granule assembly and cell survivalActivation of p90 ribosomal S6 kinase by ORF45 of Kaposi's sarcoma-associated herpesvirus and its role in viral lytic replicationRSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells.Complex formation between S100B protein and the p90 ribosomal S6 kinase (RSK) in malignant melanoma is calcium-dependent and inhibits extracellular signal-regulated kinase (ERK)-mediated phosphorylation of RSKPhosphorylation of iRhom2 at the plasma membrane controls mammalian TACE-dependent inflammatory and growth factor signalling.p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells.RSK-mediated phosphorylation in the C/EBP{beta} leucine zipper regulates DNA binding, dimerization, and growth arrest activity7-Ketocholesterol-induced inflammation signals mostly through the TLR4 receptor both in vitro and in vivo.CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma.High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors.Ribosomal S6 kinase regulates ischemia-induced progenitor cell proliferation in the adult mouse hippocampus.Excessive Na+/H+ exchange in disruption of dendritic Na+ and Ca2+ homeostasis and mitochondrial dysfunction following in vitro ischemia
P2860
Q24305925-7E47EFBF-9CA5-4355-B783-635E16059D0FQ24617480-152B89F5-883F-430C-808E-D21A83EC12FBQ24632768-DE607E1E-F1BB-4710-90D2-82E9968B06C7Q24654622-451A1D8F-0F6D-4DB5-861E-9C03CE5D0361Q24657857-251FC37E-13AF-4303-B160-E368EB321A80Q26782527-B8729ACE-BDBD-44EC-A95B-C1C112BB0440Q26827485-DD9F025C-EB5B-43B8-9D52-F512101BEE9EQ27648916-CD01FFCB-8365-4C95-9504-71D0A8F1F568Q27670966-2B4FC678-DB8E-41C5-8473-3A164B1F8E50Q27681935-398D972A-893A-4DA8-994A-9776ECF579F1Q28077322-563EF5B6-58AD-4AF2-A586-3C8E9A589184Q28086916-CBCED36B-6466-4588-A6D7-6755C1ECF323Q28115187-DE18C13F-2EE7-4E22-A689-03E44D99B4A1Q28251037-D8CF8760-FB06-4029-BA6A-76A69F6F5DB2Q28253893-934621FF-3F54-4B3C-86A3-BCF8C702D70AQ28271724-93088935-806D-4678-B0C5-8027024D744AQ28300397-13B2745E-249E-4DB7-90EB-B5A84092A39AQ28306984-2AC06A68-45AC-48A5-9AD1-086C8D950954Q28474973-FBCF8AEA-C079-4F66-96AA-2F6712F9F9D6Q28487943-28BDB1B7-DF0A-48BF-905B-19AEE4C53E7CQ28591614-EEE587C7-409E-4901-887B-CCA2DAFDFD84Q28822631-96015691-01D4-4765-AC7F-C0333226D633Q30155580-C7DFDB8C-D11B-4E74-BCBA-3056F2DB0F4BQ30275748-D44221A7-C1FB-4262-B010-6116073A2A2EQ30352429-0A4B0DB2-730B-4F7B-9457-BD344805315CQ30412077-2707B95F-8EA4-432D-9F78-2FAA5FC47FB9Q30423529-B2F8F2E1-2225-40E2-A8C3-50864E812F65Q30432330-201C0278-D1FB-4ABB-BE66-B8E00569D11DQ30438715-7EA0C74C-DEA0-4734-BF1F-39529C66C0DCQ30441657-D9F7060F-E8CA-436A-8FC1-D42E329534F2Q30547051-CE363062-27A7-49CB-A89A-A47469B0DDA7Q33556286-114D068A-11EE-4072-B5AA-4B4A45579FA6Q33704501-143B1380-1BB7-4EF8-8DE0-5EBEBD731269Q33755364-D982762E-19E2-4FA7-A416-30F1E8A9C86CQ33877036-8E03C758-EAF4-4E28-8F35-03CF7DBFCE34Q33921301-3798A187-51B0-4ABD-A5A4-D441DF80F0EFQ33974370-723D6ECD-EDB8-4707-B4E3-A87242D10E23Q33975831-85502F96-0BAB-45D6-AB4C-850A877E97C2Q34138270-B21FD5D8-6537-4602-8C2A-DA0EA75DDC10Q34251484-CC2A03F1-DC74-49B3-9A90-AE360495F7CD
P2860
BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
BI-D1870 is a specific inhibit ...... isoforms in vitro and in vivo.
@en
type
label
BI-D1870 is a specific inhibit ...... isoforms in vitro and in vivo.
@en
prefLabel
BI-D1870 is a specific inhibit ...... isoforms in vitro and in vivo.
@en
P2093
P2860
P356
P1433
P1476
BI-D1870 is a specific inhibit ...... isoforms in vitro and in vivo.
@en
P2093
Christopher Armstrong
Felicity S Newell
Gisela Schnapp
Gopal P Sapkota
Jennifer Bain
Lorna Cummings
Martin Steegmaier
Matthias Grauert
Matthias Hoffmann
Morten Frodin
P2860
P356
10.1042/BJ20061088
P407
P577
2007-01-01T00:00:00Z